Clinical Trial Update: Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating cellular, acellular, and matrix-like products (CAMPs) plus standard of care versus standard of care alone for nonhealing diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer
• Venous Leg Ulcer

Drugs mentioned

• CAMPs (cellular, acellular, and matrix-like products)
• Standard of Care

Snippet

Sponsor: Tiger Biosciences, LLC. | Conditions: Venous Leg Ulcer, Venous Leg | Phase 4 | Status: RECRUITING